· Periodic Report
Q3 revenue KRW 53.1 billion, operating loss of KRW 0.8 billion
Alico Pharm sold KRW 53.1 billion worth in Q3 but lost KRW 0.8 billion from its main business, turning from profit to loss versus a year earlier.
260660 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Alico Pharm sold KRW 53.1 billion worth in Q3 but lost KRW 0.8 billion from its main business, turning from profit to loss versus a year earlier.
Get app alerts for new disclosures from KOREA ARLICO PHARM CO.,LTD..